Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures-Reference-Cited by-同舟云学术

Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures

Published:2021-02-15 Issue:4 Volume:44 Page:1013-1020
ISSN:0141-8955
Container-title:Journal of Inherited Metabolic Disease
language:en
Short-container-title:Jrnl of Inher Metab Disea

Author:

Abdennadher Myriam¹²^ORCID,Inati Sara¹,Soldatos Ariane¹,Norato Gina¹,Baker Eva H.³,Thurm Audrey⁴,Bartolini Luca¹⁵,Masvekar Ruturaj⁶,Theodore William¹,Bielekova Bibiana⁶,Porter Forbes D.⁷,Dang Do An N.⁷

Affiliation:

1. National Institute of Neurological Disorders and Stroke, NIH Bethesda Maryland USA

2. Department of Neurology, Boston Medical Center Boston University School of Medicine Boston Massachusetts USA

3. Radiology and Imaging Sciences Department Clinical Center, NIH Bethesda Maryland USA

4. National Institute of Mental Health, NIH Bethesda Maryland USA

5. Division of Pediatric Neurology Hasbro Children's Hospital; The Warren Alpert Medical School of Brown University Providence Rhode Island USA

6. National Institute of Allergy and Infectious Diseases, NIH Bethesda Maryland USA

7. Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Bethesda Maryland USA

Funder

National Institute of Mental Health

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jimd.12366

Reference30 articles.

1. Isolation of a novel gene underlying batten disease, CLN3

2. Occurrence of and Mortality From Childhood Neuronal Ceroid Lipofuscinoses in Norway

3. Neuronal ceroid lipofuscinoses

4. Mitochondrial ATP synthase subunitc storage in the ceroid-lipofuscinoses (Batten disease)

5. Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The involvement of Purkinje cells in progressive myoclonic epilepsy: Focus on neuronal ceroid lipofuscinosis;Neurobiology of Disease;2023-09

2. Brain proton MR spectroscopy measurements in CLN3 disease;Molecular Genetics and Metabolism;2023-05

3. <b><i>CLN3</i></b>-Associated NCL Case with a Preliminary Diagnosis of Niemann Pick Type C;Molecular Syndromology;2022-06-21

4. Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment;F1000Research;2022-01-05

5. Cerebrospinal fluid neurofilament light levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment;F1000Research;2021-07-20